Yoh Zen

Active 2001–2025

151
Papers
29,256
Citations
88
h-index
142
i10-index

Citations

Citations per year for Yoh Zen1993: 1 citations2001: 3 citations2002: 9 citations2003: 7 citations2004: 24 citations2005: 31 citations2006: 51 citations2007: 76 citations2008: 106 citations2009: 178 citations2010: 251 citations2011: 220 citations2012: 248 citations2013: 223 citations2014: 276 citations2015: 258 citations2016: 221 citations2017: 207 citations2018: 178 citations2019: 793 citations2020: 836 citations2021: 648 citations2022: 457 citations2023: 361 citations2024: 649 citations2025: 269 citations2026: 4 citations1994–2000: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,226 citing papers, 19.1% of this breakdownJapan: 849 citing papers, 13.3% of this breakdownChina: 746 citing papers, 11.6% of this breakdownItaly: 414 citing papers, 6.5% of this breakdownUnited Kingdom: 394 citing papers, 6.1% of this breakdownGermany: 307 citing papers, 4.8% of this breakdownFrance: 252 citing papers, 3.9% of this breakdownSouth Korea: 190 citing papers, 3% of this breakdownCanada: 174 citing papers, 2.7% of this breakdownSpain: 162 citing papers, 2.5% of this breakdownNetherlands: 151 citing papers, 2.4% of this breakdownAustralia: 107 citing papers, 1.7% of this breakdown
0%19.1%Other 22.4%

Fields

  • Medicine83.4%
  • Biochemistry, Genetics and Molecular Biology10.5%
  • Immunology and Microbiology2.6%
  • Engineering0.9%
  • Pharmacology, Toxicology and Pharmaceutics0.9%
  • Neuroscience0.4%
  • Other1.3%

Topics

  • IgG4-Related and Inflammatory Diseases7.9%
  • Liver Disease Diagnosis and Treatment6.5%
  • Cholangiocarcinoma and Gallbladder Cancer Studies4.1%
  • Liver Diseases and Immunity4%
  • Neuroendocrine Tumor Research Advances3.9%
  • Hepatocellular Carcinoma Treatment and Prognosis2.9%
  • Other70.7%

Coauthors

All papers

Open in search
  1. The 2019 American College of Rheumatology/European League Against Rheumatism classification criteria for IgG4-related disease

    Authors: , , , , , , , , , , , , , , , , , , , - Annals of the Rheumatic Diseases 2019 cited by 739

  2. IgG4-Related Disease

    Authors: , , - New England Journal of Medicine 2012 cited by 2,597

  3. Consensus statement on the pathology of IgG4-related disease

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Ji Kon Ryu, Takako Saeki, Dushyant V. Sahani, Thomas C. Smyrk, James R. Stone, Masayuki Takahira, George Webster, Motohisa Yamamoto, Giuseppe Zamboni, Hisanori Umehara, John H. Stone - Modern Pathology 2012 cited by 2,577

  4. The 2019 American College of Rheumatology/European League Against Rheumatism Classification Criteria for IgG4‐Related Disease

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - Arthritis & Rheumatology 2019 cited by 658

  5. Nomenclature, diagnosis and management of drug-induced autoimmune-like hepatitis (DI-ALH): An expert opinion meeting report

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Anna Licata, M. Isabel Lucena, Giorgina Mieli‐Vergani, Diego Vergani, Einar S. Björnsson - Journal of Hepatology 2023 cited by 150

  6. IgG4-related disease

    Authors: , , , - The Lancet 2014 cited by 1,200

  7. 2016 Comprehensive Update of the Banff Working Group on Liver Allograft Pathology: Introduction of Antibody-Mediated Rejection

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Magda El-Monayeri, Paulo Fontes, Emma E. Furth, Annette S.H. Gouw, Sara Hafezi‐Bakhtiari, John Hart, Eva Honsová, W. Ismail, Takeshi Itoh, N. Jhala, Urmila Khettry, Göran B. Klintmalm, Stuart J. Knechtle, T Koshiba, Tomasz Kozłowski, Charles Lassman, Jan Lerut, Josh Levitsky, Lisa Licini, Rosa Liotta, George Mazariegos, Marta I. Minervini, Joseph Misdraji, Thalachallour Mohanakumar, Johan Mölne, Imad Nasser, James Neuberger, Marsha O'Neil, Orit Pappo, L. Petrovič, Phillip Ruiz, Özgül Sağol, A. Sanchez Fueyo, Eizaburo Sasatomi, Abraham Shaked, M. Shiller, Takahiro Shimizu, B. Sis, Aurelio Sonzogni, Heather L. Stevenson, Swan N. Thung, Giuseppe Tisone, Athanassios C. Tsamandas, Annika Wernerson, Ting-Jung Wu, Adriana Zeevi, Yoh Zen - American Journal of Transplantation 2016 cited by 627

  8. USP25 promotes pathological HIF-1-driven metabolic reprogramming and is a potential therapeutic target in pancreatic cancer

    Authors: , , , , , , , , , , , , , , , , , , - Nature Communications 2022 cited by 97

  9. Minimally invasive versus open distal pancreatectomy for resectable pancreatic cancer (DIPLOMA): an international randomised non-inferiority trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Per Sandström, Frederique L. Vissers, Ulrich F. Wellner, Alessandro Zerbi, Marcel G. W. Dijkgraaf, Marc G. Besselink, Mohammad Abu Hilal, Adnan Alseidi, Constanza Aquilano, Johanna Arola, Denise Bianchi, Rachel M. Brown, Daniela Campani, Joanne Chin‐Aleong, Jérôme Cros, Lyubomira Dimitrova, Claudio Doglioni, Safi Dokmak, Russell Dorer, Michael Doukas, J Fabré, Giovanni Ferrari, В. Н. Гриневич, Stefano Gobbo, Thilo Hackert, Marius van den Heuvel, Clement Huijsentruijt, Mar Iglesias, Casper Jansen, Igor Khatkov, David A. Kooby, Marco Schiavo Lena, Claudio Luchini, Krishna Menon, Patrick Michenet, Q. Molenaar, Anna Nedkova, Andrea Pietrabissa, Mihaela Raicu, Rushda Rajak, Branislava Ranković, Aniko Rendek, Benjamin Rivière, António Sá Cunha, Olivier Saint Marc, Patricia Sánchez‐Velázquez, Donatella Santini, Aldo Scarpa, Mylène Sebagh, Donald L. Sears, Mihir M. Shah, Zahir Soonawalla, Paola Spaggiari, Lars Tharun, Tore Tholfsen, Aleš Tomažič, Alessandro Vanoli, Caroline S. Verbeke, Joanne Verheij, Moritz von Winterfeld, Roeland F. de Wilde, Vincent Yip, Yoh Zen - The Lancet Regional Health - Europe 2023 cited by 123

  10. cHCC‐CCA

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Matthew M. Yeh, Yoh Zen, Jessica Zucman‐Rossi, Neil D. Theise - Hepatology 2018 cited by 331

  11. Hepatotoxicity of immune checkpoint inhibitors: a histology study of seven cases in comparison with autoimmune hepatitis and idiosyncratic drug-induced liver injury

    Authors: , - Modern Pathology 2018 cited by 288

  12. Generation of neutrophil extracellular traps in patients with acute liver failure is associated with poor outcome

    Authors: , , , , , , , - Hepatology 2021 cited by 87

  13. GREM1 is required to maintain cellular heterogeneity in pancreatic cancer

    Authors: , , , , , , , , , , , , , , , , , , , , - Nature 2022 cited by 83

  14. Long-term outcomes of autoimmune pancreatitis: a multicentre, international analysis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - Gut 2012 cited by 582

  15. Discrete nature of EpCAM+ and CD90+ cancer stem cells in human hepatocellular carcinoma

    Authors: , , , , , , , , , , , , , , , , , , - Hepatology 2012 cited by 283

  16. Dichotomy in intrahepatic cholangiocarcinomas based on histologic similarities to hilar cholangiocarcinomas

    Authors: , , , , , , , , - Modern Pathology 2017 cited by 133

  17. Application of a new histological staging and grading system for primary biliary cirrhosis to liver biopsy specimens: Interobserver agreement

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Pathology International 2010 cited by 219

  18. British Society of Gastroenterology guidelines for the diagnosis and management of cholangiocarcinoma

    Authors: , , , , , , , , , , , , , , , , , , , - Gut 2023 cited by 74

  19. Immune checkpoint inhibitor‐related cholangiopathy: Novel clinicopathological description of a multi‐centre cohort

    Authors: , , , , , , , - Liver International 2022 cited by 42

  20. Immune‐related adverse reactions in the hepatobiliary system: second‐generation check‐point inhibitors highlight diverse histological changes

    Authors: , , , , - Histopathology 2019 cited by 84

  21. Intrahepatic cholangiocarcinoma: typical features, uncommon variants, and controversial related entities

    Authors: - Human Pathology 2022 cited by 54

  22. Fibrotic phenotype of IgG4-related disease

    Authors: , , , , , , - The Lancet Rheumatology 2024 cited by 49

  23. Aberrant hepatic trafficking of gut‐derived T cells is not specific to primary sclerosing cholangitis

    Authors: , , , , , , , , , , , , , , , , , , - Hepatology 2021 cited by 46

  24. Characteristics of hepatic fatty acid compositions in patients with nonalcoholic steatohepatitis

    Authors: , , , , , , , , , , , , - Liver International 2014 cited by 145